Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Anna-Maria Dittrich

Ärzte

Hannover Medical School

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Immunology Immunology professors in Germany

Articles (12)

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (9)

Mirjam Stahl

Leader of Junior Reserach Group

GERMANY

View details

Bianca Prof. Dr. med. Schaub

Professorship

Ludwig-Maximilians-Universität München

GERMANY

View details

Kate Hill

The Queen's University Belfast

UNITED KINGDOM

View details

Karl Kunzelmann

GERMANY

View details

Rainer Schreiber

Associate professor

University of Regensburg

GERMANY

View details

Gwyneth Davies

UKRI Future Leaders Fellow/ Clinical Associate Professor

University College London Institute of Child Health

UNITED KINGDOM

View details

Julian Legg

Associate Professor

University of Southampton

UNITED KINGDOM

View details

Jobst F. Roehmel

GERMANY

View details

Paul McNally

Associate Professor

Royal College of Surgeons in Ireland

IRELAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Anna-Maria Dittrich

Research Interests

Explore related searches

Articles (12)

Partizipation von Kindern und Jugendlichen in Forschung und Versorgung

Pulmonary endpoints in clinical trials for children with cystic fibrosis under two years of age

Rigid and Flexible Bronchoscopy for Foreign Body Removal in Children: Complications, Risk Factors and Anesthetic Management

Cystic fibrosis transmembrane conductance regulator therapy with elexacaftor/tezacaftor/ivacaftor reduces detection of hallmark cystic fibrosis pathogens in Europe: progress made but no time to slow down

Elexacaftor/tezacaftor/ivacaftor in children aged ≥6 years with cystic fibrosis heterozygous for F508del and a minimal function mutation: results from a 96-week open-label extension study

Increased breath naphthalene in children with asthma and wheeze of the All Age Asthma Cohort (ALLIANCE)

Epigenetic training of human bronchial epithelium cells by repeated rhinovirus infections

Long-Term Impact of Lumacaftor/Ivacaftor Treatment on Cystic Fibrosis Disease Progression in Children 2–5 Years of Age Homozygous for F508del-CFTR: A Phase 2, Open-Label Clinical Trial

Use of elexacaftor/tezacaftor/ivacaftor leads to changes in detection frequencies of Staphylococcus aureus and Pseudomonas aeruginosa dependent on age and lung function in people with cystic fibrosis

Effects of Lumacaftor/Ivacaftor on Cystic Fibrosis Disease Progression in Children 2 through 5 Years of Age Homozygous for F508del-CFTR: A Phase 2 Placebo-controlled Clinical Trial

The Anion Channel TMEM16a/Ano1 Modulates CFTR Activity, but Does Not Function as an Apical Anion Channel in Colonic Epithelium from Cystic Fibrosis Patients and Healthy Individuals

Lung transplantation for end-stage cystic fibrosis before and after the availability of elexacaftor–tezacaftor–ivacaftor, Germany, 2012–2021

Collaborators (9)

Mirjam Stahl

Bianca Prof. Dr. med. Schaub

Kate Hill

Karl Kunzelmann

Rainer Schreiber

Gwyneth Davies

Julian Legg

Jobst F. Roehmel

Paul McNally

Make your next move.